The Nasdaq Biotechnology Index closed up 1.85%, outperforming both small-cap indices and the three major U.S. stock indices
Component stock Q32 Bio rose by 33.65%, Summit Therapeutics Plc. increased by 16.32%, and Iovance Biotherapeutics rose by 15.21%, ranking third. IGM Biosciences fell by 5.19%, ranking third from the bottom, Grail dropped by 5.37%, and Prime Medicine decreased by 5.83%